Press release
Anti-Hypertensive Drugs Market Growth, Size, Share and Forecast 2020-2026
A full report of Global Anti-Hypertensive Drugs Market is available at: https://www.omrglobal.com/industry-reports/anti-hypertensive-drugs-market
Furthermore, hypertension is a major risk factor for patients suffering from conditions such as atherosclerotic cardiovascular disease (ASCVD), heart failure, and microvascular complications. ASCVD is considered to be a leading cause of morbidity and mortality in patients with diabetes. In recent years, numerous studies have shown that anti-hypertensive drug therapy can aid in significantly reducing ASCVD events. Along with ASCVD, anti-hypertensive drugs can aid in conditions such as heart failure, and microvascular complications in diabetic patients. Hence, the positive effects of anti-hypertensive drugs on ASCVD and other conditions are anticipated to drive the anti-hypertensive drugs market growth considerably during the forecast period.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/anti-hypertensive-drugs-market
Additionally, anti-hypertensive drug-based treatment can be given to the patient either as monotherapy or in suitable combinations. In addition to this, anti-hypertensive drugs also shows good outcomes when used for non pharmacological treatment such as low salt diet, weight loss, exercise, in diabetic patients which impact the anti-hypertensive drug market. Moreover, various government organizations across the globe are involved in the study of hypertension in diabetic patients that have also suggested the use of anti-hypertensive drugs in their guidelines, which in turn, is expected to expand the anti-hypertensive drug market size.
For instance, in the guidelines from European Society of Hypertension (ESH) and European Society of Cardiology, the use of drugs such as thiazide diuretics, ?-blockers, calcium channel blockers (CCBs), ACEis and angiotensin II receptor blockers (ARBs) are recommended for the initiation and maintenance of hypertension in diabetic patients. The drugs recommended in guidelines are anti-hypertensive drugs that are preferred to be used mostly in diabetic patients. Therefore, the guidelines from ESH and European Society of Cardiology, regarding the use of anti-hypertensive drugs are expected to drive the anti-hypertensive drugs market growth significantly during the forecasted period.
Anti-Hypertensive Drugs Market- Segmentation
By Drug Class
• Thiazide Diuretics
• Calcium Channel Blockers
• ACE Inhibitors
• Angiotensin II Receptor Antagonists (ARBS)
• Beta-Blockers
• Others
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/anti-hypertensive-drugs-market
Global Anti-Hypertensive Drugs Market– Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• AstraZeneca PLC
• Bayer AG
• Boehringer Ingelheim International GmbH
• Daiichi Sankyo Co., Ltd.
• Johnson & Johnson Services, Inc.
• Lupin Ltd.
• Merck KGaA
• Noden Pharma DAC
• Novartis International AG
• Pfizer Inc.
• Ranbaxy Laboratories Ltd.
• Renata Ltd.
• Sanofi S.A.
• Sun Pharmaceuticals LLC
• Takeda Pharmaceutical Company Ltd.
• Teva Pharmaceutical Industries Ltd.
• Unichem Laboratories Ltd.
• United Therapeutics Corp.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-Hypertensive Drugs Market Growth, Size, Share and Forecast 2020-2026 here
News-ID: 2096383 • Views: …
More Releases from Orion Market Research
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033.
AI-Enabled Imaging Modalities Market Overview
The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including…
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of…
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the…
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034.
SNP genotyping Market Overview
The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
